advertisement
Buszewicz M 22
Showing records 1 to 22 | Display all abstracts from Buszewicz M81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Gazzard G
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gazzard G; Konstantakopoulou E
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Konstantakopoulou E
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garway-Heath D
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garway-Heath D; Garg A
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garg A
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Vickerstaff V
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Vickerstaff V
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Hunter R
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Hunter R
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Ambler G
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Ambler G; Bunce C
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Bunce C; Wormald R
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Wormald R
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Nathwani N
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Nathwani N
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Barton K
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Barton K; Rubin G
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Rubin G
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Buszewicz M
Lancet 2019; 393: 1505-1516
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Morris S; Buszewicz M
Health Technol Assess 2019; 23: 1-102
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Lancet 2019; 393: 1505-1516
